Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $735.95-$1,211.20 |
Market Cap | $81.8B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $13.8B |
Revenue Growth (YoY) | 10.6% |
Gross Profit (12 Mos) | $7B |
Diluted EPS | $40.43 |
News
See moreYahoo Finance • 2 months ago
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Morgan Stanley Overweight & Quality Stock?
Yahoo Finance • 2 months ago
Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?
Yahoo Finance • 2 months ago
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Yahoo Finance • 3 months ago
Regeneron Pharmaceuticals, Inc. (REGN): The Best Biotech Stock According to Hedge Funds?
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14,165 |
